BeStock  
Stocks › Biotechnology › INCY

Incyte INCY

US equityMarket cap rank #509BiotechnologyCAR-T Therapy
$119.39 −$1.96 (-1.62%)
Market open · Oct 1, 11:50 am ET · After hours $121.35 0.00%
Open$120.47
Prev close$121.35
Day range$119.02 – $121.22
Volume525.5K
Market cap$24.20B
P/E (TTM)15.2
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, not just today’s reading.

Technical signals

Trend readLeaning bearish

2 bullish · 4 bearish of 7 signals

IndicatorValueSignalReading
Price vs 20-day average-4.3%BearishTrading below the 20-day average of $124.71
Price vs 50-day average-3.4%BearishTrading below the 50-day average of $123.63
Price vs 200-day average+11.9%BullishTrading above the 200-day average of $106.66
50-day vs 200-day50d above 200dBullishThe 50-day average is above the 200-day average
RSI (14)43.5BearishMomentum leans negative
MACD (12,26,9)-0.06BearishMACD line is below its signal line
Bollinger band position-11%NeutralBelow the lower band, an extended move

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

Levels & volatility

Moving averages

AverageLevelPrice vs. it
20-day SMA$124.71-4.3%
50-day SMA$123.63-3.4%
200-day SMA$106.66+11.9%

Recent price levels

LevelPrice
20-day high$130.00
20-day low$119.97
60-day high$132.60
60-day low$110.56
Upper Bollinger band$129.06
Lower Bollinger band$120.37

The 50-day average is currently 15.9% above the 200-day average — consistent with a “golden cross” (bullish) configuration.

30-day volatility26.3%
Average true range2.65% of price
Max drawdown (1y)-18.3%
Volume (10d vs 90d)0.98x

Discussion

No comments yet — be the first to weigh in on INCY.

Leave a comment

Scroll to Top